Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 175 - 183Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Brady, RO, Gal, AE, Bradley, RM, et al. Enzymatic defect in Fabry’s disease: ceramide trihexosidase deficiency. N Engl J Med 1967; 276: 1163.Google Scholar
Brady, RO, Schiffmann, R. Clinical features and recent advances in therapy for Fabry disease. JAMA 2000; 284: 2771.CrossRefGoogle ScholarPubMed
Desnick, RJ, Brady, R, Barranger, J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138: 338.CrossRefGoogle ScholarPubMed
Garman, SC, Garboczi, DN. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 2004; 337: 319.CrossRefGoogle ScholarPubMed
Germain, DP, Hughes, DA, Nicholls, K, et al. Treatment of Fabry’s disease with the pharmacologic chaperone migalastat. N Engl J Med 2016; 375: 545.CrossRefGoogle ScholarPubMed
Nicholls, K. Fabry disease: an X-linked cause of cardiorenal syndrome. Intern Med J 2020; 50 (suppl 4): 11.Google Scholar
Bibliography
An, Y-K, Prince, D, Gardiner, F, et al. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis. Med J Aust 2019; 211: 461.Google Scholar
Burri, E, Beglinger, C. The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Rev Gastroenterol Hepatol 2014; 8: 197.CrossRefGoogle ScholarPubMed
van Rheenen, PF, van de Vijver, E, Fidler, V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010; 341: c3369.CrossRefGoogle ScholarPubMed
Wright, EK. Calprotectin or lactoferrin: do they help? Dig Dis 2016; 34: 98.CrossRefGoogle ScholarPubMed
Bibliography
van Langenberg, DR, Gearry, RB, Wong, H-L, et al. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. Intern Med J 2010; 40: 819.CrossRefGoogle ScholarPubMed
Wright, EK. Calprotectin or lactoferrin: do they help? Dig Dis 2016; 34: 98.CrossRefGoogle ScholarPubMed
Bibliography
Chauhan, A, Apostolov, R, van Langenberg, D, et al. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian perspective – effective, safe, yet room for improvement. Intern Med J 2021; 51: 106.CrossRefGoogle Scholar
Costello, SP, Bryant, RV. Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Intern Med J 2019; 49: 148.CrossRefGoogle ScholarPubMed
Costello, SP, Hughes, PA, Waters, O, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA 2019; 321: 156.Google Scholar
Hvas, CL, Jorgensen, SMD, Jorgensen, SP, et al. Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection. Gastroenterology 2019; 156: 1324.CrossRefGoogle ScholarPubMed
Soo, WT, Bryant, RV, Costello, SP. Faecal microbiota transplantation: indications, evidence and safety. Aust Prescriber 2020 43: 36.Google Scholar
Van Nood, E, Vrieze, A, Nieuwdorp, M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407.Google Scholar
Bibliography
Akar, S, Yuksel, F, Tunca, M, et al. Familial Mediterranean fever: risk factors, causes of death, and prognosis in the colchicine era. Medicine 2012; 91: 131.CrossRefGoogle ScholarPubMed
Drenth, JPH, van der Meer, JWM. Hereditary periodic fever. New Engl J Med 2001; 345: 1748.CrossRefGoogle ScholarPubMed
Eliakim, M, Levy, M, Ehrenfeld, M. Recurrent Polyserositis (Familial Mediterranean Fever, Periodic Disease). Amsterdam: Elsevier. 1981.Google Scholar
Gattorno, M, Hofer, M, Federici, S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 2019; 78: 1025.Google Scholar
Moghaddas, F. Monogenic autoinflammatory disorders: beyond the periodic fever. Intern Med J 2020; 50: 151.Google Scholar
Sohar, E, Gafni, J, Heller, H. Familial Mediterranean fever. Am J Med 1967; 43: 227.CrossRefGoogle ScholarPubMed
Bibliography
Brenton, DP, Isenberg, DA, Cusworth, DC, et al. The adult presenting Fanconi syndrome. J Inh Metab Dis 1981; 4: 211.Google Scholar
Bibliography
Spivak, JL. Felty’s syndrome: an analytical review. Johns Hopkins Med J 1977; 141: 156.Google Scholar
Bibliography
Bobbio-Pallavicni, F, Verde, G, Spirano, P, et al. Body iron status in critically ill patients: significance of serum ferritin. Intens Care Med 1989; 15: 171.CrossRefGoogle Scholar
Cullis, JO, Fitzsimons, EJ, Griffiths, WJ, et al. British Society of Haematology: investigation and management of a raised serum ferritin. Br J Haematol 2018; 181: 331.Google Scholar
Lachmann, G, Knaak, C, Vorderwulbecke, G, et al. Hyperferritinemia in critically ill patients. Crit Care Med 2020; 48: 459.Google Scholar
Bibliography
Balsara, RD, Ploplis, VA. Plasminogen activator inhibitor-1: the double-edged sword in apoptosis. Thromb Haemost 2008; 100: 1029.Google Scholar
Cap, AP. CRASH-3: a win for patients with traumatic brain injury. Lancet 2019; 394: 1687.Google Scholar
Collen, D, Lijnen, HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114.Google Scholar
CRASH-2 trial collaborators, Shakur, H, Roberts, I, Bautista, R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23.Google Scholar
Mavrommatis, AC, Theodoridis, T, Economou, M, et al. Activation of the fibrinolytioc system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intens Care Med 2001; 27: 1853.Google Scholar
Prins, MH, Hirsh, J. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. Arch Intern Med 1991; 151: 1721.Google Scholar
Saes, JL, Schols, SEM, Van Herde, WL, et al. Hemorrhagic disorders of fibrinolysis: a clinical review. Thromb Haemost 2018; 16: 1498.CrossRefGoogle Scholar
Bibliography
Elston, D. Infestations. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Bibliography
Bibliography
Dansky, LV, Rosenblatt, DS, Andermann, E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992; 42 (suppl. 5): 32.Google Scholar
McPartin, J, Halligan, A, Scott, JM, et al. Accelerated folate breakdown in pregnancy. Lancet 1993; 341: 148.Google Scholar
Wald, NJ, Bower, C. Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet 1994; 343: 307.CrossRefGoogle ScholarPubMed
Bibliography
Hirschmann, JV. Fungal, bacterial, and viral infections of the skin. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Bibliography
Mead, PS, Slutsker, L, Dietz, V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607.CrossRefGoogle ScholarPubMed
Morse, DL, Guzewich, JJ, Hanrahan, JP, et al. Widespread outbreaks of clam- and oyster-associated gastroenteritis: role of Norwalk virus. N Engl J Med 1986; 314: 678.Google Scholar
Olson, KR, ed. Poisoning and Drug Overdose. 5th edition. Norwalk: Appleton & Lange. 2006.Google Scholar
Shannon, MW, Borron, SW, Burns, MJ, eds. Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose. 4th edition. Philadelphia: WB Saunders. 2007.Google Scholar
Trujillo, MH, Guerrero, J, Fragachan, C, et al. Pharmacologic antidotes in critical care medicine: a practical guide for drug administration. Crit Care Med 1998; 26: 377.Google Scholar
Bibliography
Bagshaw, SM, Stelfox, HT, McDermid, RC, et al. Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study. CMAJ 2014; 186: E95.Google Scholar
Darvall, JN, Bellomo, R, Paul, E, et al. Frailty in very old critically ill patients in Australia and New Zealand: a population-based cohort study. Med J Aust 2019; 211: 318.Google Scholar
Bibliography
Hirschmann, JV. Fungal, bacterial, and viral infections of the skin. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar